Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Managing postoperative biochemical relapse in prostate cancer, from the perspective of the Francophone group of Urological radiotherapy (GFRU)
Authors
Keywords
-
Journal
CANCER TREATMENT REVIEWS
Volume 120, Issue -, Pages 102626
Publisher
Elsevier BV
Online
2023-09-16
DOI
10.1016/j.ctrv.2023.102626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment de‐intensification for low‐risk biochemical recurrence after radical prostatectomy: rational or risky?
- (2023) Matthew J. Roberts et al. BJU INTERNATIONAL
- Phase 2, multicenter, randomized study of salvage radiation therapy +/- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15 – GETUG-AFU 34 PROMET trial).
- (2023) Alan Dal Pra et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
- (2023) Nicolas Benziane-Ouaritini et al. European Urology Oncology
- The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy
- (2023) Matthew J. Roberts et al. BJU INTERNATIONAL
- Consensus Delineation Guidelines for Pelvic Lymph Node Radiation Therapy of Prostate Cancer: On Behalf of the Francophone Group of Urological Radiation Therapy (GFRU)
- (2023) Olivier De Hertogh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
- (2022) Matthew R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stereotactic Radiotherapy after Radical Prostatectomy in Patients with Prostate Cancer in the Adjuvant or Salvage Setting: A Systematic Review
- (2022) Christina Schröder et al. Cancers
- Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy – An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial
- (2022) A. Dal Pra et al. ANNALS OF ONCOLOGY
- Anti-Androgen Therapy Overcomes the Time Delay in Initiation of Salvage Radiation Therapy and Rescues the Oncological Outcomes in Men with Recurrent Prostate Cancer After Radical Prostatectomy: A Post Hoc Analysis of the RTOG-9601 Trial Data
- (2022) Akshay Sood et al. ANNALS OF SURGICAL ONCOLOGY
- Adjuvant Versus Early Salvage Radiation Therapy After Radical Prostatectomy for pN1 Prostate Cancer and the Risk of Death
- (2022) Derya Tilki et al. JOURNAL OF CLINICAL ONCOLOGY
- Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
- (2022) Karim Fizazi et al. LANCET
- The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial
- (2022) Alan Pollack et al. LANCET
- Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601
- (2022) William C. Jackson et al. JOURNAL OF CLINICAL ONCOLOGY
- Quality-of-Life Outcomes and Toxicity Profile Among Patients With Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multicenter Phase 2 Trial
- (2022) Ting Martin Ma et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Genomic classifiers in personalized prostate cancer radiotherapy approaches – a systematic review and future perspectives based on international consensus
- (2022) Simon K.B. Spohn et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial
- (2022) Phuoc T. Tran et al. JOURNAL OF CLINICAL ONCOLOGY
- Immediate radiotherapy versus observation in patients with node-positive prostate cancer after radical prostatectomy
- (2022) Christian Schaufler et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
- (2022) Samaneh Eickelschulte et al. Cancers
- Recurrent Prostate Cancer Diagnostics with 18F-PSMA-1007 PET/CT: A Systematic Review of the Current State
- (2022) Laura Saule et al. Diagnostics
- Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study
- (2021) Michael J. Morris et al. CLINICAL CANCER RESEARCH
- Salvage Radiotherapy Management Decision in Post-prostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance
- (2021) Olayinka A. Abiodun-Ojo et al. JOURNAL OF NUCLEAR MEDICINE
- Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
- (2021) Laila A Gharzai et al. LANCET ONCOLOGY
- Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer
- (2021) Felix Y. Feng et al. JAMA Oncology
- Validating Modern NRG Oncology Pelvic Nodal and GFRU Prostate Bed Contouring Guidelines for Post-prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial
- (2021) Grant Harmon et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study
- (2021) Kim N. Chi et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial
- (2021) Ashesh B Jani et al. LANCET
- 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review
- (2021) Soroush Rais-Bahrami et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial
- (2021) Pirus Ghadjar et al. EUROPEAN UROLOGY
- Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups
- (2021) Elio Mazzone et al. EUROPEAN UROLOGY
- Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death
- (2021) Derya Tilki et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage therapy for prostate cancer after radical prostatectomy
- (2021) Nicholas G. Zaorsky et al. Nature Reviews Urology
- Recommendations for planning and delivery of radical radiotherapy for localized urothelial carcinoma of the bladder
- (2021) Jonathan Khalifa et al. RADIOTHERAPY AND ONCOLOGY
- A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design
- (2021) Stephen J Freedland et al. BMJ Open
- Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003
- (2021) M.K. Buyyounouski et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging
- (2021) Hossein Jadvar et al. JOURNAL OF NUCLEAR MEDICINE
- Drug Intensification in Future Postoperative Radiotherapy Practice in Biochemically-Relapsing Prostate Cancer Patients
- (2021) Axel Cailleteau et al. Frontiers in Oncology
- Ten-Year Outcomes of Moderately Hypofractionated Salvage Postprostatectomy Radiation Therapy and External Validation of a Contemporary Multivariable Nomogram for Biochemical Failure
- (2020) Stephen Chin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer
- (2020) Robert T. Dess et al. JAMA Oncology
- Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
- (2020) Wanling Xie et al. JOURNAL OF CLINICAL ONCOLOGY
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer
- (2020) Philip Cornford et al. EUROPEAN UROLOGY
- NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer
- (2020) William A. Hall et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
- (2020) William T. Lowrance et al. JOURNAL OF UROLOGY
- Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data
- (2020) Claire L Vale et al. LANCET
- Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial
- (2020) Christopher C Parker et al. LANCET
- Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial
- (2020) Andrew Kneebone et al. LANCET ONCOLOGY
- Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trial
- (2020) Paul Sargos et al. LANCET ONCOLOGY
- Health-Related Quality of Life and Survival in Prostate Cancer Patients in a Real-World Setting
- (2020) Susanne Bergius et al. UROLOGIA INTERNATIONALIS
- Detection of ctDNA in plasma of patients with clinically localised prostate cancer is associated with rapid disease progression
- (2020) Edmund Lau et al. Genome Medicine
- A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
- (2020) Neil K. Jairath et al. EUROPEAN UROLOGY
- Hypofractionated Radiation Therapy to the Prostate Bed With Intensity-Modulated Radiation Therapy (IMRT): A Phase 2 Trial
- (2020) Elton Trigo Teixeira Leite et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial
- (2020) Nolan A. Wages et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostate Bed Delineation Guidelines for Postoperative Radiation Therapy: On Behalf Of The Francophone Group of Urological Radiation Therapy
- (2020) Sophie Robin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Prostate cancer recurrence in patients with negative or equivocal conventional imaging: A role for 18F-fluciclovine-PET/CT in delineating sites of recurrence and identifying patients with oligometastatic disease
- (2020) Eric H. Kim et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Phase I trial of SBRT to the prostate fossa following prostatectomy
- (2019) Leslie K. Ballas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer
- (2019) Wolfgang P. Fendler et al. JAMA Oncology
- Ten-year outcomes of moderately hypofractionated (70 Gy in 28 fractions) intensity modulated radiotherapy for localized prostate cancer
- (2019) Ibrahim Abu-Gheida et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
- (2019) Marlon Perera et al. EUROPEAN UROLOGY
- External Validation of the European Association of Urology Biochemical Recurrence Risk Groups to Predict Metastasis and Mortality After Radical Prostatectomy in a European Cohort
- (2019) Derya Tilki et al. EUROPEAN UROLOGY
- ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
- (2019) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- 18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial
- (2019) Jeremie Calais et al. LANCET ONCOLOGY
- Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
- (2019) Ian D. Davis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Impact of Circulating Tumor Cells in Patients with Localized Prostate Cancer
- (2019) Broncy et al. Cells
- Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial
- (2019) Sagus Sampath et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial
- (2019) Xin Qi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- 3-year freedom from progression following 68GaPSMA PET CT triaged management in men with biochemical recurrence post radical prostatectomy. Results of a prospective multi-center trial.
- (2019) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Salvage Radiotherapy Versus Hormone Therapy for Prostate-specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open-label, Phase 3 Trial (JCOG0401)†
- (2019) Akira Yokomizo et al. EUROPEAN UROLOGY
- 18F-rhPSMA-7 positron emission tomography for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
- (2019) Matthias Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial
- (2019) Christian Carrie et al. LANCET ONCOLOGY
- Hypofractionated radiotherapy for prostate cancer in the postoperative setting: What is the evidence so far?
- (2018) Cristina Picardi et al. CANCER TREATMENT REVIEWS
- 68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients
- (2018) Paola Caroli et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer
- (2018) Stephen J. Ramey et al. EUROPEAN UROLOGY
- Postoperative Radiation Therapy for Prostate Cancer: Comparison of Conventional Versus Hypofractionated Radiation Regimens
- (2018) Daniel J. Tandberg et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Combined abiraterone acetate plus prednisone, salvage prostate bed radiotherapy and LH-RH agonists (CARLHA-GEP12) in biochemically-relapsing prostate cancer patients following prostatectomy: A phase I study of the GETUG/GEP
- (2018) Stéphane Supiot et al. Oncotarget
- Detection efficacy of [18F]PSMA-1007 PET/CT in 251 Patients with biochemical recurrence after radical prostatectomy
- (2018) Frederik L. Giesel et al. JOURNAL OF NUCLEAR MEDICINE
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
- (2018) Thomas Van den Broeck et al. EUROPEAN UROLOGY
- Time Interval to Biochemical Failure as a Surrogate End Point in Locally Advanced Prostate Cancer: Analysis of Randomized Trial NRG/RTOG 9202
- (2018) James J. Dignam et al. JOURNAL OF CLINICAL ONCOLOGY
- A Prospective, Multi-site, International Comparison of F-18 fluoro-methyl-choline, multi-parametric magnetic resonance and Ga-68 HBED-CC (PSMA-11) in men with High-Risk Features and Biochemical Failure after Radical Prostatectomy: Clinical Performance and Patient Outcomes
- (2018) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy
- (2017) Meike Adam et al. EUROPEAN UROLOGY
- Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
- (2017) Wanling Xie et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Outcomes from68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
- (2017) Louise Emmett et al. JOURNAL OF NUCLEAR MEDICINE
- Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer
- (2017) William U. Shipley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prostate Cancer, Version 1.2014
- (2017) James L. Mohler et al. Journal of the National Comprehensive Cancer Network
- Acquisition with 11C-choline and 18F-fluorocholine PET/CT for patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis
- (2016) Finn E. von Eyben et al. ANNALS OF NUCLEAR MEDICINE
- PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
- (2016) Agostino Chiaravalloti et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
- (2016) Rahul D. Tendulkar et al. JOURNAL OF CLINICAL ONCOLOGY
- Standardizing the Definition of Biochemical Recurrence after Radical Prostatectomy—What Prostate Specific Antigen Cut Point Best Predicts a Durable Increase and Subsequent Systemic Progression?
- (2016) Amir Toussi et al. JOURNAL OF UROLOGY
- Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
- (2016) Gillian M Duchesne et al. LANCET ONCOLOGY
- Definition of lymph node areas for radiotherapy of prostate cancer: A critical literature review by the French Genito-Urinary Group and the French Association of Urology (GETUG-AFU)
- (2015) Paul Sargos et al. CANCER TREATMENT REVIEWS
- Nomogram Predicting Prostate Cancer–specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy
- (2015) John A. Brockman et al. EUROPEAN UROLOGY
- Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
- (2015) Zhenfei Li et al. NATURE
- Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy
- (2015) Changhoon Song et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer
- (2015) Sindy Magnan et al. JAMA Oncology
- Higher-than-expected Severe (Grade 3–4) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients
- (2014) Cesare Cozzarini et al. EUROPEAN UROLOGY
- Relationship between prostate-specific antigen kinetics and detection rate of radiolabelled choline PET/CT in restaging prostate cancer patients: a meta-analysis
- (2013) Giorgio Treglia et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Optimal Definition of Biochemical Recurrence After Radical Prostatectomy Depends on Pathologic Risk Factors: Identifying Candidates for Early Salvage Therapy
- (2013) Maria C. Mir et al. EUROPEAN UROLOGY
- Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized Trials
- (2013) Saroj Niraula et al. JOURNAL OF CLINICAL ONCOLOGY
- Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy
- (2012) Drew Moghanaki et al. CANCER
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?
- (2012) Ivan R. Vogelius et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Salvage radiation in men after prostate-specific antigen failure and the risk of death
- (2011) Shane E. Cotter et al. CANCER
- Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence
- (2011) Stephen A. Boorjian et al. EUROPEAN UROLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Systematic Review of the Role of Imaging before Salvage Radiotherapy for Post-prostatectomy Biochemical Recurrence
- (2009) M.J. Beresford et al. CLINICAL ONCOLOGY
- Development of RTOG Consensus Guidelines for the Definition of the Clinical Target Volume for Postoperative Conformal Radiation Therapy for Prostate Cancer
- (2009) Jeff M. Michalski et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial
- (2009) Michael E. Ray et al. JNCI-Journal of the National Cancer Institute
- Radiation Therapy After Radical Prostatectomy: Impact on Metastasis and Survival
- (2009) Stephen A. Boorjian et al. JOURNAL OF UROLOGY
- Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
- (2008) J. S. de Bono et al. CLINICAL CANCER RESEARCH
- Patient Satisfaction with Health-Related Quality of Life: Implications for Prognosis in Prostate Cancer
- (2008) Christopher G. Lis et al. Clinical Genitourinary Cancer
- Prostate Cancer–Specific Survival Following Salvage Radiotherapy vs Observation in Men With Biochemical Recurrence After Radical Prostatectomy
- (2008) Bruce J. Trock JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group
- (2008) Mark A. Sidhom et al. RADIOTHERAPY AND ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now